Celldex Therapeutics, Inc.
CLDX· Nasdaq
Released Mar 7, 2018, after the close
10-K filed Mar 7, 2018, 66 days after period end · 0001047469-18-001363
| Metric | Q4 2017 | Q4 2016 | Q4 2015 | Q4 2014 |
|---|---|---|---|---|
| Revenue | $3.46M | $1.87M | $1.79M | $1.48M |
| EPS Diluted | -$0.42 | -$0.30 | -$0.33 | -$0.36 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Celldex Therapeutics, Inc. · CIK 744218 · Engraved from SEC EDGAR